Skip to main content
. 2023 May 19;66(8):1395–1412. doi: 10.1007/s00125-023-05928-1

Fig. 5.

Fig. 5

Prognostic factors and severity of COVID-19 in individuals with diabetes and COVID-19: comorbidities and complications and other medication use. See ESM Figs. 397 for full details of the meta-analyses and Fig. 3 for the definition of severity. Renin inhibitors included ACE inhibitors, ARBs and non-specified RAS inhibitors. n.s., not specified